Related Experiment Video

Updated: Jul 27, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Prognosis of medically treated patients referred for cardiac transplantation

E Oechslin1, H P Brunner-LaRocca, G Solt

  • 1Department of Internal Medicine, University Hospital, Zürich, Switzerland.

International Journal of Cardiology
|May 14, 1998
PubMed

Insights

Patients not immediately listed for heart transplantation but managed medically showed comparable mid-term survival. However, long-term survival was worse, highlighting the need for careful monitoring and optimized medical therapy for transplant candidates.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Prognosis

Background:

  • Cardiac transplantation is a critical treatment for end-stage heart failure.
  • Determining optimal timing for transplantation versus continued medical management is challenging.
  • Patient selection for transplantation involves balancing potential benefits against risks.

Purpose of the Study:

  • To compare the prognosis and survival rates of heart transplant candidates managed with continued medical therapy versus those immediately listed for transplantation.
  • To identify factors influencing survival in medically managed transplant candidates.

Main Methods:

  • Retrospective analysis of clinical, echocardiographic, and hemodynamic data.
  • Inclusion of 160 medically treated patients considered 'too well' for immediate transplantation and 133 immediately listed patients.
  • Multivariate analysis to identify independent predictors of survival.

Main Results:

  • Forty-one medically treated patients eventually required listing after a mean of 10.7 months.
  • Mid-term (2-year) survival was similar between non-listed (74%) and immediately listed (70%) patients.
  • Long-term (5-year) survival was significantly worse for non-listed patients (41% vs. 54%, p<0.001).
  • Cardiothoracic ratio and pulmonary capillary wedge pressure were independent predictors of survival in medically treated patients with improved functional status.

Conclusions:

  • Selected medically managed heart failure patients ('too well' for transplant) have comparable mid-term prognosis to those immediately listed.
  • Optimized medical therapy can lead to good outcomes in a subgroup of patients.
  • Lower left ventricular filling pressures, smaller cardiothoracic ratio, and symptomatic improvement predict better outcomes on medical therapy.
Abstract

More Related Videos

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...